Ensign Peak Advisors’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,210
Closed -$106K 1889
2022
Q3
$106K Buy
+7,210
New +$106K ﹤0.01% 2077